PRISMA-efficacy and safety of lixisenatide for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Wei, Zhen-Gang

PRISMA-efficacy and safety of lixisenatide for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. [electronic resource] - Medicine Dec 2018 - e13710 p. digital

Publication Type: Journal Article; Meta-Analysis

1536-5964

10.1097/MD.0000000000013710 doi


Diabetes Mellitus, Type 2--drug therapy
Humans
Hypoglycemic Agents--adverse effects
Peptides--adverse effects
Randomized Controlled Trials as Topic